Cetera Advisor Networks’s Palisade Bio PALI Stock Holding History

Cetera Advisor Networks’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-29	Closed	-$2K	–	2580
2022 Q3	$2K	Buy	+29	New	+$6.14K	﹤0.01%	2082

Other funds holding PALI

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cetera Advisor Networks's PALI Position: Q4 2022 in Review

Cetera Advisor Networks sold out of Palisade Bio (PALI) in Q4 2022, closing a stake of 29 shares — an estimated $2K sold.

Cetera Advisor Networks first reported a position in PALI in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 11 funds tracked by Wall St. Rank hold PALI as of Q4 2022.

Cetera Advisor Networks reported no remaining Palisade Bio position as of Q4 2022 after selling out during the quarter.
Cetera Advisor Networks sold 29 Palisade Bio shares in Q4 2022, an estimated $2K.
Cetera Advisor Networks first reported a position in Palisade Bio in Q3 2022 and held it in 1 quarter.
Cetera Advisor Networks's Palisade Bio position peaked at $2K in Q3 2022.
11 funds tracked by Wall St. Rank held Palisade Bio as of Q4 2022.

Based on Cetera Advisor Networks's 13F filing for Q4 2022, filed 14 Feb 2023.